In the heat of summer 2025, the U.S. Senate has turned its attention to a matter that’s gripped headlines, emergency rooms, and online platforms alike: Ivermectin. Amid rising debates about alternative medications, Congress has launched a comprehensive inquiry into the use and promotion of Ivermectin, especially in the context of off-label COVID-19 treatments....